The present invention provides isolated peptides or the fragments derived from SEQ ID NO: 18, which bind to an HLA antigen and induce cytotoxic T lymphocytes (CTL). The peptides may include one of the above mentioned amino acid sequences with substitution, deletion, or addition of one, two, or several amino acids. The present invention also provides pharmaceutical compositions including these peptides. The peptides of the present invention can be used for treating cancer.本發明提供源自序列辨識號:18之經分離的胜肽或片段,其結合至一人類白血球組織抗原且誘導細胞毒殺性T淋巴球。胜肽可包括具有一、二或數個胺基酸之取代、刪除或加入之上述胺基酸序列之一。本發明也提供包括這些胜肽的藥學組合物。本發明胜肽也可用來治療癌症。
